<DOC>
	<DOCNO>NCT02862366</DOCNO>
	<brief_summary>Patients myeloproliferative neoplasm Philadelphia chromosome negative ( MPNsPh1- ) Essential thrombocytosis ( ET ) , Polycythemia vera ( PV ) Primary Myelofibrosis ( PMF ) high risk arterial deep-vein thrombosis . This responsible significant increase mortality ( 31 % increase thrombosis risk ET ) . Cellular inflation blood hyperviscosity , result disease , fail account thromboses , 50 % thrombotic complication happen adapt antineoplastic drug treatment . These last year , cellular microparticles ( MPs ) show play major role thrombogenesis . MPs generate apoptosis activation malignant cell , platelet , endothelial cell monocyte . They fragment plasma membrane , small 1 Âµm , rich phosphatidylserine , express tissue factor serve support coagulation factor . Increase plasma concentration procoagulant platelet microparticles demonstrate thrombotic disease ( acute coronary syndrome , disseminate intravascular coagulation DIC , etc. ) . The work hypothesis platelet microparticles involve hypercoagulability MPNs patient .</brief_summary>
	<brief_title>Role Circulating Procoagulants Microparticles Hypercoagulability MNP Ph1-</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<criteria>Inclusion Criteria MNPs patient : Age &gt; 18 Establish MNPs Phi diagnosis ( ET , PV , MFP ) Consent participate Inclusion Criteria healthy volunteer : Healthy volunteer match age , sex MNPs patient , normal complete blood platelet count No personal thromboembolic history No known thromboembolic risk factor : thrombophilia , cancer , disease associate thrombotic risk ( Atrial fibrillation , etc . ) Not pregnant Non smoker For woman , hormonal contraceptive Exclusion Criteria MNPs patient : Pregnancy Patient unable give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>myeloproliferative neoplasm</keyword>
	<keyword>Circulating Procoagulants Microparticles</keyword>
</DOC>